Show Summary Details
Page of

Symptomatic therapy 

Symptomatic therapy
Chapter:
Symptomatic therapy
Author(s):

Richard J Glassock

DOI:
10.1093/med/9780198784081.003.0002
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 27 November 2020

Patients with glomerular diseases develop a wide variety of biochemical disturbances and pathophysiologic alterations leading to overt clinical manifestations. Collectively, these abnormalities give rise to the classical syndromes of glomerular disease. The clinical abnormalities resulting from these disturbances in renal pathophysiology require management in order to minimize or avoid disabling symptoms, often referred to as symptomatic therapy. This chapter provides an introduction to and overview of these abnormalities. It then covers therapies for a variety of manifestations of primary glomerular diseases, including haematuria, oedema, hypertension, hyperlipidaemia (e.g. hypercholesterolaemia), the ‘hypercoagulable’ or ‘thrombophilic’ state, non-disease-specific strategies designed to retard the progression of renal disease (loss of glomerular filtration rate, GFR), and more.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.